Vistagen Therapeutics, Inc. (VTGN): Total Assets
$48.56M
As of 2026-03-31
$35.74M
As of 2026-06-30
+32.1%
3-year compound annual growth
-14.8%
5-year compound annual growth
+47.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $48.56M | -42.4% | 2026-06-15, Balance as of period end |
| 2025-03-31 | $84.34M | -31.8% | 2026-06-15, Balance as of period end |
| 2024-03-31 | $123.65M | +486.3% | 2025-06-17, Balance as of period end |
| 2023-03-31 | $21.09M | -71.7% | 2024-06-11, Balance as of period end |
| 2022-03-31 | $74.64M | -31.1% | 2023-06-28, Balance as of period end |
| 2021-03-31 | $108.28M | n/m | 2022-06-23, Balance as of period end |
| 2020-03-31 | $5.77M | -58.8% | 2021-06-29, Balance as of period end |
| 2019-03-31 | $14.01M | +24.2% | 2020-06-29, Balance as of period end |
| 2018-03-31 | $11.28M | +203.8% | 2019-06-25, Balance as of period end |
| 2017-03-31 | $3.71M | +275.0% | 2018-06-26, Balance as of period end |
| 2016-03-31 | $989.8K | +267.0% | 2017-06-29, Balance as of period end |
| 2015-03-31 | $269.7K | +2.3% | 2016-06-24, Balance as of period end |
| 2014-03-31 | $263.7K | -70.1% | 2015-06-29, Balance as of period end |
| 2013-03-31 | $881.5K | +158.1% | 2014-06-25, Balance as of period end |
| 2012-03-31 | $341.6K | +5.6% | 2013-07-18, Balance as of period end |
| 2011-03-31 | $323.6K | n/a | 2012-07-02, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $48.56M | -42.4% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $8.75M | -11.7% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $7.02M | -35.2% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $28.71M | +0.4% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $81.29M | +204.1% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.93M | +9.7% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $34.75M | +60.4% |
| Bespoke Extracts, Inc. (BSPK) | 2024-12-31 | $359.1K | +1.3% |
Compare VTGN, IGC, LGVN, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗